lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
271 rows where filing_period = "third_quarter", filing_year = 2018 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2178393 | MYRIAD GENETIC LABORATORIES, INC. 4fc8fb08-74d4-4244-8141-e093fd70a24d | 3T | MYRIAD GENETIC LABORATORIES, INC. | 400821434 | MYRIAD GENETIC LABORATORIES, INC. | 2018 | third_quarter | MED | Regulation of laboratory developed tests - discussion draft (no HR #) Diagnostic Accuracy and Innovation Act (DAIA) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 1 | 2018-09-04T10:26:46.050000-04:00 | |
| 2178445 | FAEGRE BAKER DANIELS CONSULTING ca63a747-6646-4726-8aeb-63f044a514f6 | 3T | FAEGRE BAKER DANIELS CONSULTING | 34158 | MYRIAD GENETIC LABORATORIES, INC. | 2018 | third_quarter | MED | FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2018-09-07T12:05:11.177000-04:00 | |
| 2178658 | COUNCIL OF GRADUATE SCHOOLS 07ea53e9-3c33-446c-b2e6-be7acdef5abe | Q3 | COUNCIL OF GRADUATE SCHOOLS | 11071 | COUNCIL OF GRADUATE SCHOOLS | 2018 | third_quarter | MED | n/a | Education, Dept of,HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,U.S. Agency for International Development (USAID) | 0 | 0 | 2018-09-18T13:26:40.207000-04:00 | ||
| 2178929 | FRANCIS EDWARD & CRONIN, INC. 6f59b845-b255-43fc-ae8a-7518749794dd | Q3 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2018 | third_quarter | MED | Legislation related to Alzheimer's disease research. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 20000 | 0 | 0 | 2018-10-01T09:09:22.097000-04:00 | |
| 2178930 | FRANCIS EDWARD & CRONIN, INC. fb753a48-2924-48ea-8cf4-ba50300723c9 | Q3 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2018 | third_quarter | MED | Issues and legislation related to diabetes diagnosis and treatment. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2018-10-01T09:11:22.970000-04:00 | ||
| 2179055 | MARSHALL BRACHMAN c3dd178c-34d4-4784-9bd9-8cd13c2c629a | Q3 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2018 | third_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2018-10-01T11:38:03.783000-04:00 | |
| 2179150 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION ec5c649c-86f4-445c-900b-f4e6bd3d37ae | Q3 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 59650 | AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 2018 | third_quarter | MED | Lobbied in support of increased funding for the NIH, NIDDK, NCI and federal research funding for DoD and the VA. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 80000 | 0 | 0 | 2018-10-01T12:52:53.590000-04:00 | |
| 2179374 | OTT BIELITZKI & O'NEILL PLLC 90a164f0-935b-4338-b06f-351835c8f2a0 | Q3 | OTT BIELITZKI & O'NEILL PLLC | 401103584 | BIOPORTO DIAGNOSTICS A/S | 2018 | third_quarter | MED | BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals. | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2018-10-01T21:10:37.197000-04:00 | |
| 2179388 | ACT FOR NIH 7d33ce9c-0334-427f-bd59-c4e11a6c5699 | Q3 | ACT FOR NIH | 401103441 | ACT FOR NIH | 2018 | third_quarter | MED | Advocacy efforts to increase funding for NIH. | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2018-10-02T07:21:44.213000-04:00 | |
| 2179420 | RAY C CULVER III a1b703ac-28b2-4b87-baa0-e5422ad0af03 | Q3 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2018 | third_quarter | MED | Funding for the USDA Agricultural Research Service human nutrition research centers in the FY19 House and Senate Agricultural Appropriations bills currently being conferenced (HR 6147) and the 2018 "farm bill" reauthorization (HR 2). | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-10-02T10:33:06.140000-04:00 | |
| 2179431 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 8bde4d53-5583-4c6d-98c8-4a1f136f7f51 | Q3 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2018 | third_quarter | MED | VA Research funding and access issues;--VA Missions Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2018-10-02T11:28:14.257000-04:00 | |
| 2180494 | KUTAK ROCK LLP 8f8bc2e3-c597-4d44-8829-b5c2ea6f30b4 | Q3 | KUTAK ROCK LLP | 21962 | NE ENTERPRISES | 2018 | third_quarter | MED | Reauthorization of Pandemic and All Hazards Preparedness Act and related matters. | 20000 | 0 | 0 | 2018-10-05T13:25:22.780000-04:00 | ||
| 2180523 | NATURAL RESOURCE RESULTS LLC 7d8eb11b-49fa-43bb-ad56-e4a91d9b1439 | Q3 | NATURAL RESOURCE RESULTS LLC | 321555 | SHINE MEDICAL TECHNOLOGIES | 2018 | third_quarter | MED | Support funding for cooperators on NNSA program for medical isotope production under AMIPA. | Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 10000 | 0 | 0 | 2018-10-05T13:50:39.003000-04:00 | |
| 2180663 | BROYDRICK & ASSOCIATES 392941b2-7cb4-42bc-bdd0-6bfcea284013 | Q3 | BROYDRICK & ASSOCIATES | 7268 | EXACT SCIENCES | 2018 | third_quarter | MED | Legislation on cancer screening test process. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2018-10-05T18:22:10.497000-04:00 | |
| 2180927 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION f7cc014e-b53b-42c1-9be6-ecb93cb7869f | Q3 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 401103437 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 2018 | third_quarter | MED | DoD funding for melanoma research | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-10-08T15:27:07.087000-04:00 | |
| 2181028 | BROWN RUDNICK LLP 832d5db2-43e2-4038-a79d-a589982b5791 | Q3 | BROWN RUDNICK LLP | 287895 | HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS) | 2018 | third_quarter | MED | Diagnostic Accuracy & Innovation Act (DAIA)Discussion Draft | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-08T21:28:07.380000-04:00 | |
| 2181103 | NEOGENOMICS LABORATORIES 29e975d0-143e-4abd-a56e-432f45f18404 | Q3 | NEOGENOMICS LABORATORIES | 401105014 | NEOGENOMICS LABORATORIES | 2018 | third_quarter | MED | Diagnostic Accountability and Innovation Act (DAIA) Protecting Access to Medicare Act (PAMA) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-09T10:48:13.310000-04:00 | |
| 2181119 | AMERICAN COLLEGE OF CLINICAL PHARMACY 61fbbf6e-5870-49bb-b3a5-341437eec39d | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2018 | third_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2018-10-09T10:59:25.970000-04:00 | |
| 2181209 | FEDERAL SOLUTIONS, LLC fc4a6d1f-b14e-4a3e-a77b-d934472185f1 | Q3 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2018 | third_quarter | MED | Labor/HHS/Education Appropriation Bill: Provisions relating to disease research. | Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2018-10-09T12:23:17.510000-04:00 | |
| 2181265 | TCH GROUP, LLC 489a47ed-2241-4dd8-8946-e81325389852 | Q3 | TCH GROUP, LLC | 51478 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2018 | third_quarter | MED | FY 19 House and Senate State Foreign Operations Subcommittee Appropriations bills (HR 6385 and S 3108) and also the FY 19 Continuing Resolution (HR 6157). Specifically, continued Federal funding under USAID for AIDS vaccine research and development | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-09T13:33:47.503000-04:00 | |
| 2181671 | O'NEILL AND ASSOCIATES d1fd3db5-ff81-42e6-870f-860f60683f85 | Q3 | O'NEILL AND ASSOCIATES | 73134 | POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) | 2018 | third_quarter | MED | Medicare advantage and health care reform | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-10T10:14:05.330000-04:00 | |
| 2181808 | JEFFREY J. KIMBELL & ASSOCIATES, INC. d7c22ecf-777e-4745-ac8f-bd0cedf6fb26 | Q3 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 46038 | SANTHERA PHARMACEUTICALS (USA), INC. | 2018 | third_quarter | MED | Issues related to development of treatments for rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-10-10T12:04:21.500000-04:00 | |
| 2181812 | JEFFREY J. KIMBELL & ASSOCIATES, INC. 04a858b7-d64e-4750-a159-ee5fa272d808 | Q3 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 46038 | SPECTRUM PHARMACEUTICALS, INC. | 2018 | third_quarter | MED | Issues related to development of oncology treatments | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-10-10T12:09:24.250000-04:00 | ||
| 2181818 | MR. BRIAN KELLY 890c052a-2fd6-425a-9342-3841a28bb4e8 | Q3 | MR. BRIAN KELLY | 40024191 | INTELLIA THERAPEUTICS | 2018 | third_quarter | MED | Gene Editing | Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office | 15000 | 0 | 0 | 2018-10-10T12:12:30.110000-04:00 | |
| 2182050 | POYNER SPRUILL LLP 811957dc-10c2-4a75-8a84-0ee3a7934e74 | Q3 | POYNER SPRUILL LLP | 400563685 | AMERICAN COLLEGE OF SPORTS MEDICINE, INC. | 2018 | third_quarter | MED | vital role of physical activity and sports, fitness (including the President's Council on Physical Fitness, Nutrition and Sports), worksite wellness activities, disease prevention through healthy lifestyles, promotion of good health and diet, funding for Labor, HHS and Education Appropriation Bills, concussion legislation, good nutrition and infrastructure initiatives for pedestrians and cyclists and other health-related matters. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE | 6600 | 0 | 0 | 2018-10-10T15:06:51.757000-04:00 | |
| 2182150 | MCDERMOTT+ LLC 5f7200bd-f618-46ac-b0c2-e56299ca6492 | Q3 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2018 | third_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2018-10-10T18:16:56.240000-04:00 | |
| 2182395 | CAPITOL HILL CONSULTING GROUP fec6be19-c880-4116-9e52-03c1b6e6c940 | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES | 2018 | third_quarter | MED | Government funding of medical research. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-11T11:24:18.413000-04:00 | |
| 2182544 | THE O TEAM LLC b1985af5-f0bf-47f4-b6e7-a3c81bbb7378 | Q3 | THE O TEAM LLC | 400783359 | THE SUZANNE WRIGHT FOUNDATION | 2018 | third_quarter | MED | Pancreatic cancer awareness. Health Advanced Research Projects Agency (HARPA) Advocacy. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-10-11T14:08:26.417000-04:00 | |
| 2182806 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 27956ac9-60ea-4657-911a-1d1d3555e598 | Q3 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CITY OF HOPE MEDICAL CENTER | 2018 | third_quarter | MED | Medicare/Medicaid reimbursement, clinical research | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-11T17:01:02.657000-04:00 | |
| 2182851 | THE PETRIZZO GROUP, INC. 82e0c1e2-06f2-4292-9a7e-90603c9650fe | Q3 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2018 | third_quarter | MED | Advocated for funding of the BRAIN Initiative, Alzheimer's and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-11T19:34:23.373000-04:00 | |
| 2182917 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 8c0f0b30-2aa6-46f2-841b-f8b550a6ce97 | Q3 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2018 | third_quarter | MED | NIH funding HHS budget bill, PREA re-authorization, cancer moonshot, Children's Hospital Graduate Medical Education, 340B drug pricing, Children's Health Insurance Program reauthorizartion, Children's Hospital graduate medical education, Neonatal abstinence syndrome, ACE kids act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 50890 | 0 | 0 | 2018-10-12T09:20:02.407000-04:00 | |
| 2182945 | SQUIRE PATTON BOGGS 21360548-87e1-47bd-9901-0d3fe706e7bc | Q3 | SQUIRE PATTON BOGGS | 30906 | THOMAS JEFFERSON UNIVERSITY | 2018 | third_quarter | MED | Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-10-12T09:35:14.423000-04:00 | |
| 2183006 | GRIZZLE COMPANY 59f45003-268a-4e58-b22a-b77fa57dfe3f | 3A | GRIZZLE COMPANY | 16987 | UNIVERSITY OF LOUISVILLE | 2018 | third_quarter | MED | Request letters of support for NIGMS grant application. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-12T10:10:31.460000-04:00 | |
| 2183229 | THE CJR GROUP, INC. 1a7ae8a0-41f7-477f-9673-e4c21c18e0e0 | Q3 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2018 | third_quarter | MED | Issues impacting hospitals | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-10-12T12:16:49.693000-04:00 | |
| 2183365 | FAEGRE DRINKER BIDDLE & REATH LLP 7eec90bf-8ba0-439f-9241-262155cd3012 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2018 | third_quarter | MED | Neglected Tropical Disease Research and Development; H.R. 6378, Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act. | SENATE | 10000 | 0 | 0 | 2018-10-12T13:41:46.193000-04:00 | |
| 2183524 | FAEGRE DRINKER BIDDLE & REATH LLP d50bdd42-9d4e-4cc8-9b1b-94080b611379 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH | 2018 | third_quarter | MED | H.R. 6378 Pandemic All Hazards Preparedness Act Reauthorization; S.2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) | 30000 | 0 | 0 | 2018-10-12T15:18:55.050000-04:00 | |
| 2183528 | FAEGRE DRINKER BIDDLE & REATH LLP 0aa634f0-4fa6-422d-a7cd-ff75ea8cd0b1 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2018 | third_quarter | MED | Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research; H.R. 6378 Pandemic and All Hazards Preparedness Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; H.Res. 1062 Resolution supporting the goals to protect US military personnel from malaria. | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 50000 | 0 | 0 | 2018-10-12T15:20:55.770000-04:00 | |
| 2183631 | THE CONAFAY GROUP, LLC f5603219-93ce-462a-9583-a4ff53b41b3a | Q3 | THE CONAFAY GROUP, LLC | 401004840 | THE COALITION FOR ACCESS TO PRENATAL SCREENING | 2018 | third_quarter | MED | Genetic testing. | HOUSE OF REPRESENTATIVES | 0 | 0 | 2018-10-12T18:19:35.713000-04:00 | ||
| 2183829 | THE PETRIZZO GROUP, INC. fb70f6f4-6572-4e13-adaf-7be84f91a618 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | UNITED BIOMEDICAL, INC. | 2018 | third_quarter | MED | Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases. | HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2018-10-14T12:52:00.860000-04:00 | |
| 2183832 | THE PETRIZZO GROUP, INC. e2b7a365-c438-4acc-bfc9-8ba7bc2924c6 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2018 | third_quarter | MED | Advocated for Medicare Part B packaged payment reform. | HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE | 75000 | 0 | 0 | 2018-10-14T12:56:01.673000-04:00 | |
| 2184310 | EFB ADVOCACY, LLC 0d7fc495-667e-42ac-b83e-a522ad906756 | Q3 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2018 | third_quarter | MED | Funding issues related to National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2018-10-15T12:55:58.930000-04:00 | |
| 2184316 | MARIJUANA POLICY PROJECT 18f3470a-9668-4b35-9a1c-9ceca56aadd6 | Q3 | MARIJUANA POLICY PROJECT | 74330 | MARIJUANA POLICY PROJECT | 2018 | third_quarter | MED | Advocated easing restrictions on researching marijuana (no specific bill at this point) | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2018-10-15T13:01:02.417000-04:00 | |
| 2184420 | INTUITIVE SURGICAL, INC. 2a278941-1aa6-4e7f-bfaf-f2ea3d946478 | Q3 | INTUITIVE SURGICAL, INC. | 400670004 | INTUITIVE SURGICAL, INC. | 2018 | third_quarter | MED | comparative effectiveness research in healthcare | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-10-15T14:07:50.327000-04:00 | |
| 2184949 | UNIVERSITY OF SOUTH FLORIDA 7a18050d-4d59-4adf-8068-51ade25376f9 | Q3 | UNIVERSITY OF SOUTH FLORIDA | 401081033 | UNIVERSITY OF SOUTH FLORIDA | 2018 | third_quarter | MED | General support for NIH research programs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-16T08:37:41.407000-04:00 | |
| 2184956 | AMERICAN PHYSICAL THERAPY ASSOCIATION 7aa8818a-4a89-4e25-94c1-a5cc5b57eadb | Q3 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2018 | third_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding AHRQ Quality measure development panel for hip fracture patients and fall risk in PAC Comments on Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Known Risk Factors PT role in childhood obesity Relocate TBI State Grant Program to ACL SAFE PLAY Act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Veterans Affairs, Dept of (VA),White House Office | 251000 | 0 | 0 | 2018-10-16T08:50:42.393000-04:00 | |
| 2185305 | SQUIRE PATTON BOGGS 724c1d69-d1ac-4bd9-a849-7e9b83313f07 | Q3 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2018 | third_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2018-10-16T11:50:02.617000-04:00 | |
| 2185331 | W STRATEGIES, LLC a9b9622e-4b75-499f-8b7a-6ab06ebd5f34 | Q3 | W STRATEGIES, LLC | 400605842 | 23ANDME, INC. | 2018 | third_quarter | MED | Issues related to regulation of Direct to Consumer (DTC) Genetic Testing and education and outreach regarding genetic testing and personalized medicine, including FDA regulation of DTC tests and privacy in consumer genetics. FDA draft guidance related to regulatory oversight of laboratory developed tests and the development of legislation related to oversight of LDTs. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-16T11:55:12.757000-04:00 | |
| 2185390 | MYRIAD GENETIC LABORATORIES, INC. 2f822c48-d4b9-45d7-a5d6-33e2d59ab3c8 | 3@ | MYRIAD GENETIC LABORATORIES, INC. | 400821434 | MYRIAD GENETIC LABORATORIES, INC. | 2018 | third_quarter | MED | Regulation of laboratory developed tests - discussion draft (no HR #) Diagnostic Accuracy and Innovation Act (DAIA) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 160000 | 0 | 1 | 2018-10-16T12:06:34.260000-04:00 | |
| 2185746 | BUCHANAN INGERSOLL & ROONEY PC 6fe74fae-ce6f-4ff9-b166-a8cf1ea22cb8 | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | TISSUEGENE, INC. | 2018 | third_quarter | MED | Federal government relations service, strategy development and implementation relating to regenerative medicine products. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-16T14:05:00.897000-04:00 | |
| 2185838 | THE CORMAC GROUP, LLC 01d49c7b-826f-47eb-9fac-80071bf8440c | Q3 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2018 | third_quarter | MED | Appropriations, DOD, TBI Research, Veterans Issues | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-16T14:26:36.277000-04:00 | |
| 2185882 | ALZHEIMER'S FOUNDATION OF AMERICA e2944582-03df-4589-a5cf-afff832d34c3 | Q3 | ALZHEIMER'S FOUNDATION OF AMERICA | 323158 | ALZHEIMER'S FOUNDATION OF AMERICA | 2018 | third_quarter | MED | S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, Home Health Care Planning Act | Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 37000 | 0 | 0 | 2018-10-16T14:41:52.043000-04:00 | |
| 2186073 | SQUIRE PATTON BOGGS c99fea37-a45f-4f5a-a788-823b7abf7204 | Q3 | SQUIRE PATTON BOGGS | 30906 | IMPACT JOURNALS, LLC | 2018 | third_quarter | MED | National Library of Medicine publication and archive matters. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2018-10-16T15:15:54-04:00 | |
| 2186150 | FAEGRE DRINKER BIDDLE & REATH LLP 264f18eb-b811-4a1c-8a3f-697be487a8e9 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | MARCH OF DIMES FOUNDATION | 2018 | third_quarter | MED | (HR. 6085, S. 3029) PREEMIE Re-authorization Act. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-16T15:27:14.720000-04:00 | |
| 2186211 | FAEGRE DRINKER BIDDLE & REATH LLP 7930154c-8b6b-44be-9d49-3c5aeba2dfed | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREECLAMPSIA FOUNDATION | 2018 | third_quarter | MED | Preeclampsia Research Issues. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-10-16T15:37:28.503000-04:00 | |
| 2186442 | AMERICAN SOCIETY OF ADDICTION MEDICINE a6ee55b3-5aa4-48e8-9f5b-727118ce3318 | Q3 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2018 | third_quarter | MED | 1.S. 2317/H.R. 3692 - Addiction Treatment Access Improvement Act - amend the Controlled Substances Act to provide for additional flexibility with respect to medication-assisted treatment for opioid use disorders, and for other purposes. 2.H.R. 6 - SUPPORT for Patients and Communities Act - provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. 3.S. 2608 - Opioid Crisis Response Act - address the opioid crisis 4.H.R. 5605 - Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act - provide for an opioid use disorder treatment demonstration program, and for other purposes 5.H.R. 5797 - Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act - provide under Medicaid services for certain individuals with opioid use disorders in institutions for mental diseases. 6.H.R. 5800 - the Medicaid IMD ADDITIONAL INFO Act - require the Medicaid and CHIP Payment and Access Commission to conduct an exploratory study and report on requirements applicable to and practices of institutions for mental diseases under the Medicaid program. 7.H.R. 5483 - Special Registration for Telemedicine Clarification Act - impose a deadline for the promulgation of interim final regulations in accordance with section 311(h) of the Controlled Substances Act (21 U.S.C. 831(h)) specifying the circumstances in which a special registration may be issued to a practitioner to engage in the practice of telemedicine, and for other purposes. 8.H.R. 5272 - a bill to ensure that programs and activities that are funded by a grant, cooperative agreement, loan, or loan guarantee from the Department of Health and Human Services, and whose purpose is to prevent or treat a mental health or substance use disorder, are evidence-based 9.S. 2524/H.R. 5102, Substance Use Disorder Workforce Loan Repayment Act - amend the Public Health Service Act to authorize a loan repayment program for substance use disorder treatment employees, and for other purposes 10.H.R. 4005 - the Medicaid… | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 60000 | 0 | 0 | 2018-10-16T16:48:06.103000-04:00 | |
| 2186501 | LNE GROUP 70f3a7c2-6fae-439f-b7f1-ecb4854a40a0 | Q3 | LNE GROUP | 308811 | HOSPICE OF THE WESTERN RESERVE | 2018 | third_quarter | MED | Lobbied on issues related to medical/disease research. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2018-10-16T17:18:24.413000-04:00 | ||
| 2186626 | GREENBERG TRAURIG, LLP a7ad382b-20bc-4d06-8324-acf9c350f493 | Q3 | GREENBERG TRAURIG, LLP | 16896 | AMERICAN SOCIETY INTERVENTIONAL PAIN PHYSICIANS | 2018 | third_quarter | MED | Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement. Outreach and monitoring related to federal issues and legislation associated with health care policy. Outreach and monitoring related to federal issues and legislation associated with opioids. H.R. 6, SUPPORT for Patients and Communities Act. H.R. 1628, The Better Care Reconciliation Act of 2017. H.R. 3635, Local Coverage Determination Clarification Act of 2017. H.R. 5804, Post-Surgical Injections as an Opioid Alternative Act. S. 794, Local Coverage Determination Clarification Act of 2017. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-10-16T18:31:07.797000-04:00 | |
| 2186754 | TRAVERE THERAPEUTICS 56db97d3-cddb-4921-946b-6c43e79a2049 | Q3 | TRAVERE THERAPEUTICS | 401104190 | TRAVERE THERAPEUTICS | 2018 | third_quarter | MED | Medical research, NIH funding, related appropriations issues | HOUSE OF REPRESENTATIVES,SENATE | 220000 | 0 | 0 | 2018-10-16T22:45:04.840000-04:00 | |
| 2186881 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 5a817186-f545-45ad-bd11-ab766f630e9e | Q3 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS | 52105 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS | 2018 | third_quarter | MED | Work to enhance funding for NIH. Support funding for the Peer Reviewed Orthopaedic Research Program Opioid legislation | HOUSE OF REPRESENTATIVES,SENATE | 653881 | 0 | 0 | 2018-10-17T09:21:08.253000-04:00 | |
| 2186892 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS a78f009f-9e0a-4b77-8373-821806f9bf14 | Q3 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 1375 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2018 | third_quarter | MED | Opioid Legislation | HOUSE OF REPRESENTATIVES,SENATE | 6735 | 0 | 0 | 2018-10-17T09:32:14.943000-04:00 | |
| 2187180 | LNE GROUP c44e1592-53a7-424c-a632-5b3e54205f49 | Q3 | LNE GROUP | 308811 | PARKER HANNIFIN | 2018 | third_quarter | MED | Lobbied for issues related to medical research. | HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG) | 80000 | 0 | 0 | 2018-10-17T10:46:52.560000-04:00 | |
| 2187528 | UNIVERSITY OF IOWA d636c755-9a57-4c37-8f49-c2f1a4c99ae4 | Q3 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2018 | third_quarter | MED | Support for all federal agencies that fund medical and disease research FY 19 appropriations for HHS, NIH, CDC, and DOD FY 19 appropriations for Injury Prevention Centers at CDC FY 19 appropriations for NIDCR | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 50000 | 0 | 0 | 2018-10-17T11:32:45.247000-04:00 | |
| 2187535 | SQUIRE PATTON BOGGS ac298037-df0d-4de9-ab55-95368a109b1c | Q3 | SQUIRE PATTON BOGGS | 30906 | MOLNLYCKE HEALTH CARE US, LLC | 2018 | third_quarter | MED | Working with congressional leaders to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-10-17T11:34:48.813000-04:00 | |
| 2187730 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 53ff5d4a-7b58-4db4-add1-3fb380f871ea | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2018 | third_quarter | MED | Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017 | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2018-10-17T12:31:04.207000-04:00 | |
| 2187755 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8bf2619a-1bde-4988-918b-9b7539dbc07a | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2018 | third_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2018-10-17T12:34:09.927000-04:00 | |
| 2187927 | IMPACT HEALTH POLICY PARTNERS aa987d27-dfc5-4e85-8263-6f1e2d705d16 | Q3 | IMPACT HEALTH POLICY PARTNERS | 401104696 | ABBOTT LABORATORIES | 2018 | third_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-10-17T13:21:22.900000-04:00 | |
| 2187940 | IMPACT HEALTH POLICY PARTNERS 8e791416-21ee-4ad1-8934-8c0c949bd6dd | Q3 | IMPACT HEALTH POLICY PARTNERS | 401104696 | HACKENSACK MERIDIAN HEALTH | 2018 | third_quarter | MED | Issues related to research funding, NIH and other matters. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-17T13:27:27.713000-04:00 | |
| 2187959 | IMPACT HEALTH POLICY PARTNERS ca72f5b6-62cf-4931-a76f-8bb6fc4c89b2 | Q3 | IMPACT HEALTH POLICY PARTNERS | 401104696 | CHILDREN'S HOSPITAL COLORADO | 2018 | third_quarter | MED | Issues related to pediatric research and childrens hospital graduate medical education. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-17T13:33:36.543000-04:00 | |
| 2188039 | FAMILY RESEARCH COUNCIL cab99b07-b14d-4b5b-9858-1a8923e103ce | Q3 | FAMILY RESEARCH COUNCIL | 14110 | FAMILY RESEARCH COUNCIL | 2018 | third_quarter | MED | HR 5520 VA Medicinal Cannabis Research Act of 2018. Research on Veterans and marijuana. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2018-10-17T13:48:03.027000-04:00 | |
| 2188188 | THE CORMAC GROUP, LLC 29c7020a-8829-4a35-9bdd-955b38179179 | Q3 | THE CORMAC GROUP, LLC | 66773 | HEARTFLOW, INC. | 2018 | third_quarter | MED | Medicare payment issues | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-17T14:18:54.547000-04:00 | |
| 2188226 | SQUIRE PATTON BOGGS dd5bc367-8af2-406b-8631-806db916d67a | Q3 | SQUIRE PATTON BOGGS | 30906 | UNIVERSITY OF GEORGIA | 2018 | third_quarter | MED | Traumatic brain injury and regenerative medicine research, funding, and outreach opportunities. | Agriculture, Dept of (USDA),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 40000 | 0 | 0 | 2018-10-17T14:31:13.033000-04:00 | |
| 2189059 | BRACEWELL LLP 196db000-91b9-4a98-b866-7c463d7cdb67 | Q3 | BRACEWELL LLP | 6837 | NATIONAL BRAIN TUMOR SOCIETY | 2018 | third_quarter | MED | work related to the advancement of the Cancer Drug Coverage Parity Act and STAR Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2018-10-17T16:39:03.297000-04:00 | |
| 2189167 | UNIVERSITY OF ROCHESTER a1d67154-08f1-4a50-bc86-a2c34feca222 | Q3 | UNIVERSITY OF ROCHESTER | 301937 | UNIVERSITY OF ROCHESTER | 2018 | third_quarter | MED | P.L. 114-255, 21st Century Cures Act | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2018-10-17T17:05:31.647000-04:00 | |
| 2189278 | STANFORD UNIVERSITY 30924054-b794-4ea5-a22a-61bd7ae4b5cb | Q3 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2018 | third_quarter | MED | Affordable Care Act Reform Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs Precision Medicine Initiative | Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,Treasury, Dept of | 80000 | 0 | 0 | 2018-10-17T17:43:57.167000-04:00 | |
| 2189326 | CARDINAL HEALTH, INC. 4704bd06-8530-4b71-a2b4-0cf1623da907 | Q3 | CARDINAL HEALTH, INC. | 58055 | CARDINAL HEALTH INC | 2018 | third_quarter | MED | Medical Device Tax - H.R. 184 and S. 108 | Federal Emergency Management Agency (FEMA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 790000 | 0 | 0 | 2018-10-17T18:55:14.907000-04:00 | |
| 2189677 | PARALYZED VETERANS OF AMERICA a6701ebe-a5ba-4092-8d2a-ff349fc15fb0 | Q3 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2018 | third_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | AMTRAK - Natl Railroad Passenger Corporation,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA) | 46327 | 0 | 0 | 2018-10-18T09:05:31.320000-04:00 | |
| 2189718 | HOLLAND & KNIGHT LLP 69eda070-ce39-450a-8638-abe9ce00279b | Q3 | HOLLAND & KNIGHT LLP | 18466 | PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION | 2018 | third_quarter | MED | Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2019 Ag-FDA Appropriations bills and reports (H.R. 5961, S.2976); H.Res.282 on sunscreen use in schools; Sunscreen provisions in H.R. 5333, the Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018, and S.2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act; issues related to state bans on sunscreen ingredients. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-18T09:12:40.820000-04:00 | |
| 2189892 | FEDERAL ADVOCATES, INC. c82306b6-27f5-4b37-9b5d-3e80e30a51e6 | Q3 | FEDERAL ADVOCATES, INC. | 308172 | CANNDESCENT | 2018 | third_quarter | MED | USDOJ/DEA approval of cannabis/marijuana research facilities. | HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 90000 | 0 | 0 | 2018-10-18T09:46:53.637000-04:00 | |
| 2189929 | BAKER BOTTS, L.L.P. b45aeb76-f9ef-4898-bf10-eed7309e76c2 | Q3 | BAKER BOTTS, L.L.P. | 5118 | SOUTHERN METHODIST UNIVERSITY | 2018 | third_quarter | MED | Funding of research into detecting traumatic brain injury. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-18T09:53:11.183000-04:00 | |
| 2190082 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 499762dc-4f90-4928-8421-0317371f9906 | Q3 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | COLOR HEALTH (FKA COLOR GENOMICS) | 2018 | third_quarter | MED | Lobbying related to healthcare issues. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-10-18T10:16:01.233000-04:00 | |
| 2190133 | WILLIAMS AND JENSEN, PLLC f71f34f9-d5db-4c5a-82f1-a686a159f37f | Q3 | WILLIAMS AND JENSEN, PLLC | 41454 | GLOBAL DOWN SYNDROME FOUNDATION | 2018 | third_quarter | MED | Support for down syndrome research funding. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40000 | 0 | 0 | 2018-10-18T10:21:22.767000-04:00 | |
| 2190239 | BALCH & BINGHAM, LLP a5646339-55ee-441b-94a6-2ff98e0a6f4d | Q3 | BALCH & BINGHAM, LLP | 5197 | TRANSCENDENCE, INC. | 2018 | third_quarter | MED | New medical innovations for improved treatment. | 20000 | 0 | 0 | 2018-10-18T10:28:00.203000-04:00 | ||
| 2190630 | WILLIAMS AND JENSEN, PLLC 96fc7860-826c-4b75-ac0b-e4608818d0ea | Q3 | WILLIAMS AND JENSEN, PLLC | 41454 | MT PHARMA AMERICA, INC. | 2018 | third_quarter | MED | Matters affecting access to pharmaceuticals. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-18T11:07:14.597000-04:00 | |
| 2190791 | WILLIAMS AND JENSEN, PLLC 32ae77d9-5c08-4a32-a8c4-150af0d45ba1 | Q3 | WILLIAMS AND JENSEN, PLLC | 41454 | VERTEX PHARMACEUTICALS INCORPORATED | 2018 | third_quarter | MED | Prescription drug user fee agreements and general education about FDA approval policies and NIH research activities. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-10-18T11:30:22.133000-04:00 | |
| 2190809 | WILLIAMS AND JENSEN, PLLC c8162bb2-41a6-4e7b-b34f-766e71e77bff | Q3 | WILLIAMS AND JENSEN, PLLC | 41454 | SANOFI, U.S. | 2018 | third_quarter | MED | General education about FDA approval policies and NIH research activities. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-10-18T11:32:29.210000-04:00 | |
| 2190835 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f8388658-998b-4bf1-96a7-3ecb95d6c40a | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2018 | third_quarter | MED | Research in Endocrinology, Standardization of Hormone Testing | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2018-10-18T11:35:40.650000-04:00 | |
| 2191031 | BALLARD PARTNERS 9d68d809-2ebb-4d7f-97b2-a62cf201bd61 | Q3 | BALLARD PARTNERS | 401104288 | THE SUZANNE WRIGHT FOUNDATION | 2018 | third_quarter | MED | Establishing a Funding Source for Medical Research | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2018-10-18T12:03:00.683000-04:00 | |
| 2191162 | BALLARD PARTNERS b5828d74-1c73-4143-8aa7-47de815d63a2 | Q3 | BALLARD PARTNERS | 401104288 | LABORATORY CORPORATIONS OF AMERICA HOLDINGS | 2018 | third_quarter | MED | Clinical Lab Rates | White House Office | 80000 | 0 | 0 | 2018-10-18T12:24:55.247000-04:00 | |
| 2191195 | EASTERSEALS, INC d11974b3-e7a9-4b37-a0c6-4432ac05cf28 | Q3 | EASTERSEALS, INC | 27720 | EASTERSEALS, INC. | 2018 | third_quarter | MED | PL 108173: Medicare Prescription Drug and Modernization Act of 2003; PL 111148: Patient Protection and Affordable Care Act; PL 111-152, 124 Stat. 1029: Health Care and Education Reconciliation Act of 2010; PL 113157: Autism CARES (Collaboration, Accountability, Research, Education and Support) Act of 2014; HR 1628: American Health Care Act of 2017; FY 2019 Labor, Health and Human Services, Education Appropriations; HR 1628: American Health Care Act of 2017/Better Care Reconciliation Act of 2017; HR 2824: Increasing Opportunity and Success for Children and Parents through Evidence-Based Home Visiting Act; HR 3759/S 1028: Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act (PL 115-119); S 1827/HR 3921: Children's Health Insurance Program (CHIP); S 1829/HR 2824: Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program; HR 3778: Direct CARE (Creation, Advancement, and Retention of Employment) Opportunity Act; and HR 5306/S 2227: Ensuring Medicaid Provides Opportunities for Widespread Equality, Resources (EMPOWER) Care Act; and H.R. 5912/S. 2897: To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services and home health services furnished without an electronic visit verification system, and for other purposes. | Administration for Children & Families (ACF),Defense, Dept of (DOD),Education, Dept of,Equal Employment Opportunity Commission (EEOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Council on Disability,SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),U.S. Architectural & Transportation Barriers Compliance Board (ACCESS),Veterans Affairs, Dept of (VA),White House Office | 46018 | 0 | 0 | 2018-10-18T12:33:04.657000-04:00 | |
| 2191354 | MYRIAD GENETICS, INC. 502ae626-a527-4eae-9ebc-b8ae51a78244 | 3A | MYRIAD GENETICS, INC. | 401104995 | MYRIAD GENETICS, INC. | 2018 | third_quarter | MED | Regulation of laboratory developed tests - discussion draft in House - The Diagnostic Accuracy and Innovation Act (DAIA); no HR # | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-10-18T13:12:10.003000-04:00 | |
| 2191545 | P STREET PROJECT, INC. 456300a7-dec0-442e-ac1b-11a9625d6b80 | Q3 | P STREET PROJECT, INC. | 400637928 | P STREET PROJECT, INC. | 2018 | third_quarter | MED | Public health insurance option and Medicare for All (S. 1804); advocating against repeal of ACA | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-10-18T13:53:08.930000-04:00 | ||
| 2191628 | CAPITOL HILL STRATEGIES, LLC 24fff3bb-9775-4dee-89d6-754f37ee9490 | Q3 | CAPITOL HILL STRATEGIES, LLC | 91774 | SANOFI US SERVICES INC. | 2018 | third_quarter | MED | H.R. 5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-10-18T14:06:27.603000-04:00 | |
| 2191678 | UNIVERSITY OF MIAMI f6c78ec8-44e2-476c-8cb2-9ba7fa0cf066 | Q3 | UNIVERSITY OF MIAMI | 39462 | UNIVERSITY OF MIAMI | 2018 | third_quarter | MED | Fire Fighter Cancer | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 100500 | 0 | 0 | 2018-10-18T14:10:36.730000-04:00 | |
| 2191787 | NELSON MULLINS RILEY & SCARBOROUGH fabca21e-e2b5-4fb1-9293-672643edc36d | Q3 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | WEEDMAPS | 2018 | third_quarter | MED | Research and development of medicines and treatment alternatives | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-10-18T14:31:17.263000-04:00 | |
| 2191917 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e8ff8883-843b-4d3f-8693-97628c2a481b | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2018 | third_quarter | MED | HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, Tuberous Sclerosis Medical Research program NIH and CDC, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2018-10-18T14:50:01.240000-04:00 | |
| 2191989 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 692cfe03-a904-4dac-8232-6c8e02cdbb30 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PANCREATIC CANCER ACTION NETWORK (PANCAN) | 2018 | third_quarter | MED | HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, Peer-Reviewed Cancer Research Program, NIH Funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2018-10-18T14:56:21.067000-04:00 | |
| 2192019 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2bb1eb66-ea4c-4f1e-b704-ef36d6c58a13 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION | 2018 | third_quarter | MED | Research opportunities at the Department of Defense and the Centers for Disease Control. HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, defense medical research, NIH Funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2018-10-18T14:58:30.070000-04:00 | |
| 2192101 | CAPITOL HILL STRATEGIES, LLC ad1d3889-0f06-4e5e-862c-0f80a63b9299 | Q3 | CAPITOL HILL STRATEGIES, LLC | 91774 | BIOGEN INC | 2018 | third_quarter | MED | Issues dealing with newborn screening. Issues dealing with Alzheimer's treatments. Issues dealing with the addition of Spinal Muscular Atrophy to the Recommended Uniform Screening Panel. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-10-18T15:04:53.357000-04:00 | |
| 2192294 | WILLIAMS AND JENSEN, PLLC 55e64b05-7f01-4d5a-bb70-53d559088274 | Q3 | WILLIAMS AND JENSEN, PLLC | 41454 | ECRI INSTITUTE | 2018 | third_quarter | MED | General education regarding patient safety Initiatives, medical product safety, and evidence-based healthcare information to improve patient care. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-10-18T15:26:58.327000-04:00 | |
| 2192362 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY f69decc0-b59c-471d-9b7c-6c75c8f996a4 | Q3 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2018 | third_quarter | MED | Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases | Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office | 60400 | 0 | 0 | 2018-10-18T15:31:16.313000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);